Dr. Oern Stuge
And finally for this week dysphagia treatment company Phagenesis has appointed Dr. Oern Stuge, former senior executive at Medtronic and Abbott Laboratories, as Chairman.
Dr. Stuge will replace Henry Hyde Thomson who said: “In the three years I have served as Chairman, Phagenesis has grown from a start-up to a revenue-generating company which has successfully launched its dysphagia treatment. Dr Stuge’s extensive experience in the field of medical devices will help ensure Phagenesis’ continued success as it rolls out this vital treatment to patients and their carers around the world.”